CNSX:CHV

(CHV) Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume156,525 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

(CHV) (CNSX:CHV) Vs. PREV, COM, MYM, CURE, HALO, and LTY

Should you be buying CHV stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to (CHV), including (PREV) (PREV), 138267 (COM.TO) (COM), 17031 (MYM), Direxion Daily Healthcare Bull 3X Shares (CURE), Halozyme Therapeutics (HALO), and Liberty Biopharma (LTY).

(PREV) (CNSX:PREV) and (CHV) (CNSX:CHV) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.

Profitability

This table compares (PREV) and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
(CHV)N/AN/AN/A

Valuation and Earnings

This table compares (PREV) and (CHV)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
(CHV)N/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and price targets for (PREV) and (CHV), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
(CHV)0000N/A

138267 (COM.TO) (TSE:COM) and (CHV) (CNSX:CHV) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.

Profitability

This table compares 138267 (COM.TO) and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
138267 (COM.TO)N/AN/AN/A
(CHV)N/AN/AN/A

Valuation and Earnings

This table compares 138267 (COM.TO) and (CHV)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
(CHV)N/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and price targets for 138267 (COM.TO) and (CHV), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
138267 (COM.TO)0000N/A
(CHV)0000N/A

17031 (CNSX:MYM) and (CHV) (CNSX:CHV) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for 17031 and (CHV), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
170310000N/A
(CHV)0000N/A

Profitability

This table compares 17031 and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
17031N/AN/AN/A
(CHV)N/AN/AN/A

Valuation and Earnings

This table compares 17031 and (CHV)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
17031N/AN/AN/AN/AN/A
(CHV)N/AN/AN/AN/AN/A

(CHV) (CNSX:CHV) and Direxion Daily Healthcare Bull 3X Shares (CNSX:CURE) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability.

Analyst Recommendations

This is a summary of current ratings and recommmendations for (CHV) and Direxion Daily Healthcare Bull 3X Shares, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Direxion Daily Healthcare Bull 3X Shares0000N/A

Profitability

This table compares (CHV) and Direxion Daily Healthcare Bull 3X Shares' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
Direxion Daily Healthcare Bull 3X SharesN/AN/AN/A

Earnings & Valuation

This table compares (CHV) and Direxion Daily Healthcare Bull 3X Shares' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Direxion Daily Healthcare Bull 3X SharesN/AN/AN/AN/AN/A

(CHV) (CNSX:CHV) and Halozyme Therapeutics (NEO:HALO) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability.

Analyst Recommendations

This is a summary of current ratings and recommmendations for (CHV) and Halozyme Therapeutics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Halozyme Therapeutics00014.00

Halozyme Therapeutics has a consensus target price of C$0.27, suggesting a potential upside of ∞.

Profitability

This table compares (CHV) and Halozyme Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
Halozyme TherapeuticsN/AN/AN/A

Earnings & Valuation

This table compares (CHV) and Halozyme Therapeutics' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Halozyme TherapeuticsC$267.59 million0.00C$130.40 millionC$0.91N/A

Halozyme Therapeutics has higher revenue and earnings than (CHV).

Summary

Halozyme Therapeutics beats (CHV) on 2 of the 2 factors compared between the two stocks.

(CHV) (CNSX:CHV) and Liberty Biopharma (CVE:LTY) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability.

Analyst Recommendations

This is a summary of current ratings and recommmendations for (CHV) and Liberty Biopharma, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Liberty Biopharma0000N/A

Profitability

This table compares (CHV) and Liberty Biopharma's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
Liberty BiopharmaN/AN/AN/A

Earnings & Valuation

This table compares (CHV) and Liberty Biopharma's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Liberty BiopharmaN/AN/AN/AC($0.16)-12.66


(CHV) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
HALO
Halozyme Therapeutics
1.7N/AN/AC$0.00C$267.59 million47.00
LTY
Liberty Biopharma
0.6$2.00flatC$0.00N/A-12.66Gap Down
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
News Coverage
SCYB
Scythian Biosciences
0.5$3.49flatC$0.00N/A0.00High Trading Volume
ABCN
VIVO Cannabis
0.6$1.32flatC$0.00N/A0.00Gap Down
VP
Vodis Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.